Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5745)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 14, 2022 (publication date) through May 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu YZ, Wu M, Zheng XH, Wang BZ, Xue LY, Ding SK, Yang L, Ren JS, Tian YT, Xie YB. No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer. World J Gastroenterol 2022; 28(38): 5589-5601 [PMID: 36304092 DOI: 10.3748/wjg.v28.i38.5589] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i38/5589.htm |
| Number | Citing Articles |
| 1 |
Gao-shi Huang, Ying Xie, Zhen-yu Jiang, Zhang-qun Xu, Zheng-jia Jin, Ke-chen Xu. Clinical analysis of sustained-release 5-fluorouracil implants during surgery for advanced gastric cancer. Current Problems in Surgery 2025; 66: 101746 doi: 10.1016/j.cpsurg.2025.101746
|